Cite
HARVARD Citation
Rosenthal, A. et al. (n.d.). A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR‐CD) for untreated low‐grade non‐Hodgkin lymphoma requiring therapy. American journal of hematology. 92 (5), pp. 467-472. [Online].